Optimal infiltration depth threshold for low-temperature plasma ablation in fungal keratitis

真菌性角膜炎低温等离子体消融术的最佳浸润深度阈值

阅读:1

Abstract

PURPOSE: To identify prognostic factors and their optimal thresholds influencing the treatment outcome of low-temperature plasma ablation therapy in patients with fungal keratitis (FK). METHODS: The clinical information of fifty-one patients with FK treated with low-temperature plasma ablation at Xiamen Eye Center from 2018 to 2024 was retrospectively analyzed. Patients were categorized into Responder and Non-Responder groups based on their response to treatment: complete/partial healing (Responder group) versus disease progression or need for additional surgery (Non-Responder group). Differences in demographic and clinical characteristics between the two groups were compared. Additionally, exact univariate and multivariate logistic regression were performed to identify prognostic factors. Lastly, receiver operating characteristic (ROC) curve analysis was utilized to determine the cut-off value for significant prognostic factors. RESULTS: Among the 51 patients, 37 were classified in the Responder group and 14 in the Non-Responder group. Univariate analysis revealed significant differences in the presence of hypopyon (p = 0.038), ulcer size (p = 0.002), infiltration depth (p = 0.001), and paracentral ulcer location (p = 0.030) between the groups. Multivariate analysis identified infiltration depth (adjusted odds ratio [aOR] = 1.41, 95% CI: 1.05-1.91, p = 0.024) as the sole significant independent prognostic factor. ROC analysis demonstrated excellent discrimination ability for infiltration depth, with an area under the curve of 0.966. Finally, the optimal threshold for infiltration depth was determined to be 0.48, exhibiting a sensitivity of 92.86% and specificity of 91.89%. CONCLUSIONS: Low-temperature plasma ablation represents an effective treatment for FK, with infiltration depth serving as a crucial prognostic indicator. The identified threshold provides valuable guidance for patient selection. Nonetheless, larger prospective studies are warranted to validate these findings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。